Hyperinsulinemia associated with increased insulin resistance is a demand for insulin secretion, and this event thought to reflect increased secretory capacity from the β-cells as a compensatory response for reducing blood glucose level during T2DM [59, 60]. This evidence concerns the gene INS and Insulin resistance.